South Africa & Moderna

South Africa: South Africa has pledged $2.5 million to support the Ebola response, contributing to international efforts to contain the outbreak.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

South Africa: South Africa, through its epidemiologists, is observing the Ebola outbreak and providing expert commentary on its rapid spread and challenges.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

South Africa: South Africa's President, Cyril Ramaphosa, is the African Union Champion for Pandemic Preparedness, Prevention and Response and was consulted on the PHECS declaration.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.